Article
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
4 Mar 2015
Abstract excerpt
The activating/co-stimulatory receptor NKG2D (natural-killer group 2, member D) is expressed on the surface of all human NK, NKT, CD8(+) T, and subsets of γδ(+) T cells. The significance of NKG2D function in tumor immunity has been well demonstrated in experimental animal models. However, the role of human NKG2D ligands in regulating tumor immunity and cancer prognosis had been controversial in the literature. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
